Ervin Steve Woodle

18PUBLICATIONS
46CO-AUTHORS
PharmacogenomicsRegenerative medicine (incl. stem cells)Cell development, proliferation and deathApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 11, 2024
Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations.

Nicole K Wilson, Simon Tremblay, Adele R Shields

|Nov 15, 2023
The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells.

Trini A Ochoa, Amy Rossi, E Steve Woodle

|May 03, 2023
Carfilzomib-based antibody mediated rejection therapy in pediatric kidney transplant recipients.

Ellen M Cody, Charles Varnell, Danielle Lazear

|Jul 13, 2021
Plasma cell biology: Foundations for targeted therapeutic development in transplantation.

Amy P Rossi, Rita R Alloway, David Hildeman

|Jul 08, 2021
Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance: Two-Year Results of a Prospective, Randomized Multicenter Trial.

Dixon B Kaufman, E Steve Woodle, Adele Rike Shields

Pageof 3